retatrutide other name There's a new in the GLP conversation — and it's worth paying attention to. is a triple-agonist therapy that targets GLP-1, GIP, and glucagon receptors simultaneously. In clinical trials Retatrutide is the newest name
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25


























